Skip to content
MedsAcross

Medicine

Dicyclomine 40 mg tablet

Dicyclomine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Dicyclomine 40 mg tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…

Key facts

Active ingredient (INN)
Dicyclomine
Brand
Sold under the generic name
Strength
40 mg
Dosage form
Tablet
Route
Oral
Packs
1000 tablets, 100 tablets, 60 tablets and 4 more
Manufacturers
Advagen PharmaTrifluent Pharma
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A03AA07 Dicyclomine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
25 March 2025
Identifiers
RxCUI 2719470, 991086DailyMed set ID 56282794-5874-4220-b25c-cea4b17d19aa, b4331e24-58af-45fb-a25b-9eb8270f83f7NDC 73352-119, 72888-198Application ANDA216736

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1000 tablet in 1 bottle72888-198-00Advagen Pharma25 March 2025
100 tablet in 1 bottle72888-198-01Advagen Pharma25 March 2025
60 tablet in 1 bottle72888-198-02Advagen Pharma1 November 2026
500 tablet in 1 bottle72888-198-05Advagen Pharma25 March 2025
120 tablet in 1 bottle72888-198-12Advagen Pharma25 March 2025
30 tablet in 1 bottle72888-198-30Advagen Pharma17 February 2026
60 tablet in 1 bottle73352-119-60Trifluent Pharma14 July 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 11 May 1950Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Dicyclomine

Clinical summary

Dicyclomine is an anticholinergic indicated for the treatment of patients with functional bowel/irritable bowel syndrome. It is available as tablets, capsules and injection for oral and intramuscular use. MedsAcross supplies Dicyclomine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Dicyclomine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Dicyclomine 40 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.